Literature DB >> 20667778

Patients' perceptions of communication with the health care team during chemotherapy for the first recurrence of ovarian cancer.

Eva Ekwall1, Britt-Marie Ternestedt, Bengt Sorbe, Ulla Hällgren Graneheim.   

Abstract

AIM: The aim of this study was to explore what women with recurrent ovarian cancer perceived as important in their communication with the health care team.
METHOD: Interviews were conducted with 12 women at the end of chemotherapy treatment at a department of gynecological oncology in central Sweden. The interviews were subjected to qualitative content analysis.
RESULTS: The findings stress the importance for the health care team to offer each woman the opportunity for support in becoming familiar with the disease. This theme of becoming familiar with the disease is underpinned by four sub-themes: being acknowledged as a unique person, getting help to make sense of information regarding the disease and its treatment, having the opportunity to be involved and to share responsibility, and feeling confident that medical expertise was adequate. Becoming familiar with the disease was expressed as a process of understanding and assimilating the whole new situation. To achieve familiarity, the women needed help from the health care team to make sense of the information they received. They stressed the importance of being able to influence encounters with health professionals, in accordance with their own perspectives. Being acknowledged as a unique person was a prerequisite to achieve familiarity. Also important to the women was having the opportunity to share responsibility for their care and lives with someone from the health care team.
CONCLUSION: Helping women with recurrence of ovarian cancer attain a sense of familiarity with the disease should be an important priority for health care providers.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20667778     DOI: 10.1016/j.ejon.2010.06.001

Source DB:  PubMed          Journal:  Eur J Oncol Nurs        ISSN: 1462-3889            Impact factor:   2.398


  6 in total

1.  Prevalence of cancer chemotherapy-related problems, their relation to health-related quality of life and associated supportive care: a cross-sectional survey.

Authors:  Richard Wagland; Alison Richardson; Sean Ewings; Jo Armes; Elaine Lennan; Matthew Hankins; Peter Griffiths
Journal:  Support Care Cancer       Date:  2016-07-27       Impact factor: 3.603

2.  The Patient-Healthcare Professional Relationship and Communication in the Oncology Outpatient Setting: A Systematic Review.

Authors:  Anne Prip; Kirsten Alling Møller; Dorte Lisbet Nielsen; Mary Jarden; Marie-Helene Olsen; Anne Kjaergaard Danielsen
Journal:  Cancer Nurs       Date:  2018 Sep/Oct       Impact factor: 2.592

3.  Emotional Bond: The Nature of Relationship in Palliative Care for Cancer Patients.

Authors:  Mir Hossein Aghaei; Zohreh Vanaki; Eesa Mohammadi
Journal:  Indian J Palliat Care       Date:  2020-01-28

4.  Parents' experiences of collaboration between welfare professionals regarding children with anxiety or depression - an explorative study.

Authors:  Catharina Widmark; Christer Sandahl; Katarina Piuva; David Bergman
Journal:  Int J Integr Care       Date:  2013-10-31       Impact factor: 5.120

5.  Patient, physician, and caregiver perspectives on ovarian cancer treatment decision making: lessons from a qualitative pilot study.

Authors:  Rachel Pozzar; Laura-Mae Baldwin; Barbara A Goff; Donna L Berry
Journal:  Pilot Feasibility Stud       Date:  2018-07-04

6.  HAPPY - Humanity Assurance Protocol in interventional radiotheraPY (brachytherapy) - an AIRO Interventional Radiotherapy Study Group project.

Authors:  Valentina Lancellotta; Vitaliana De Sanctis; Patrizia Cornacchione; Fernando Barbera; Vincenzo Fusco; Cristiana Vidali; Sara Scalise; Giulia Panza; Angela Tenore; Giuseppe Ferdinando Colloca; Renzo Corvò; Maria Antonietta Gambacorta; Stefano Maria Magrini; Luca Tagliaferri
Journal:  J Contemp Brachytherapy       Date:  2019-12-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.